 In 2019 Neuzil and the Center for Vaccine Development at the University of Maryland School of Medicine announced a seven-year $200 million contract with the National Institute of Allergy and Infectious Diseases.The research program will test seasonal influenza vaccines and will feature clinical trials with populations including pregnant women, children and the elderly.She has spoken about the need for the public to have an influenza vaccine (flu shot), ideally by the end of October.